Watch CBS News

'I'll Tell You What', Mark Cuban Trolls Cole Beasley After Anti-COVID Vaccine Tweet

DALLAS (CBSDFW.COM) - Dallas Mavericks' owner Mark Cuban went to war, a Twitter war that is, with Buffalo Bills wide receiver Cole Beasley over his anti-COVID vaccine rhetoric shared via the football player's social media this summer.

"I'll get vaccinated and be an advocate for it if Pfizer puts a percentage of its earnings from the vaccine in my wife's name," Beasley tweeted in reply to an article suggesting that the NFL should stop testing players for marijuana if they receive their COVID-19 vaccine.

To which Cuban replied: "I'll tell you what Cole. You get vaccinated and promote vaccination on all your social, I'll buy your wife a share of Pfizer stock. It pays a 3.78% dividend. That way she is getting a percentage of Pfizer's earnings. Deal?"

It is not clear if Beasley's stance was sarcasm to make a point or an actual position he would adopt.

Beasley first tweeted his anti-COVID vaxx stance when the NFL announced its COVID protocols for vaccinated vs. unvaccinated players. He took the NFLPA to task for agreeing to the organization's terms. Restrictions on close contact remain for the unvaccinated, while the vaccinated can carry-on unimpeded for the first time since the 2019 season. But Beasley hasn't stopped tweeting about the issue, even coming for former Cowboys great Michael Irvin on July 19.

Irvin had tweeted: If you're unvaccinated that means you don't want to win badly enough.

Beasley argues that it comes down to personal choice. "I have never told any player what to do with their body. Not one. I'm not gonna tell them they don't wanna win if they choose to not inject a knee or whatever just so they could play that day when they can barely walk. That is their choice to make the decision they think is best," he tweeted.

CBS 11 News will let you know if that happens.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.